The Diagnostic Pitfalls of Mucormycosis.

Authors :: Mauro M
Lo Cascio G
Balter R
Zaccaron A
Bonetti E
Vitale V
Chinello M
De Bortoli M
Brazzarola P
Bruno C
Cesaro S
Source :: Mediterranean journal of hematology and infectious diseases [Mediterr J Hematol Infect Dis] 2020 Nov 01; Vol. 12 (1), pp. e2020079. Date of Electronic Publication: 2020 Nov 01 (Print Publication: 2020).
Publication Year :: 2020
Abstract: Background: Invasive mucormycosis is a very aggressive fungal disease among immunocompromised pediatric patients caused by saprophytic fungi that belong to the order of the Mucorales.<br />Case Report: We describe a case of of Lichtheimia corymbifera infection in a 15-year-old child with B-cell-Non-Hodgkin Lymphoma (B-NHL) involving lung, kidney and thyroid that initially was diagnosed as probable aspergillosis delaying the effective therapy for mucormycosis.<br />Conclusions: This case showed that also the intensive chemotherapy for B-NHL may represent a risk factor for mucormycosis infection. Liposomal amphotericin B and surgery remain the key tools for the successful treatment of this aggressive disease.<br />Competing Interests: Competing interests: The authors declare no conflict of Interest.